You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Scholars advise the next president to prioritize the role of the science and technology advisor.
A blogger describes the switch to massively parallel sequencing.
Darwin abounds in the news.
The University of Toronto tries out a "graduate student oath."
GSK donates microarray data to caBIG.
GenBank contains a lot of wrong information.
A blogger discusses the structure of the specific aims page of an R01 grant application.
A healthy lifestyle can alter gene expression to protect against cancer, a study indicates.
A blogger writes about really good scientific meetings.
Innovation in Europe is held back by significant delays at patent offices, BBC News reports.
A Dow Jones article looks at companies getting into biomarker-based diagnostics and personalized medicine.
This week's issue looks at a Canadian biobank, behavioral genetics, aligning genomic sequences, and more.
A NYT blogger discusses the merits of Charles Darwin.
Maryland's governor plans a biosciences initiative.
In Nature this week, there's evolution of quaternary structure, the ERC, an amphioxus genome, and more.
Bloggers discuss the validity of scientific theories.
Bloggers discuss what it means to be human.
California's objection to direct-to-consumer genetic testing has bloggers in a tizzy.
Registration for Google Code Jam is open.
Emory researchers make mouse cells that produce magnetic particles.
Jeremy Nicholson talks about metabolomics in a Q&A.
A study on genetic reasons why people don't learn from their mistakes, makes a mistake.
A professor who once taught the governor of Louisiana lobbies on behalf of evolution.
A gene expression study suggests you can get the benefits of coffee just by smelling it.
NYT covers a genome sequence-based image intended to promote personalized medicine.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.